作者：
Hosseinipour, Mina C. [1]
;
Innes, Craig [2]
;
Naidoo, Sarita [3]
;
Mann, Philipp [4]
;
Hutter, Julia [5]
;
Ramjee, Gita [6]
;
Sebe, Modulakgotla [7]
;
Maganga, Lucas [8]
;
Herce, Michael E. [9]
;
DeCamp, Allan C. [10]
;
Marshall, Kyle [11]
;
Dintwe, One [12]
;
Andersen-Nissen, Erica [13]
;
Tomaras, Georgia D. [14]
;
Mkhize, Nonhlanhla ;
Morris, Lynn ;
Jensen, Ryan ;
Miner, Maurine D. ;
Pantaleo, Giuseppe ;
Ding, Song ;
Van der Meeren, Olivier ;
Barnett, Susan W. ;
McElrath, M. Juliana ;
Corey, Lawrence ;
Kublin, James G.
作者单位：
FuroVacc Fdn, Lausanne, Switzerland
[1]
GSK Vaccines, Rixensart, Belgium
[2]
Duke Univ, Duke Human Vaccine Inst, Sch Med, Durham, NC USA
[3]
Univ N Carolina, Chapel Hill, NC 27515 USA
[4]
Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[5]
Univ Lausanne, Ctr Hosp Univ Vaudois, Div Immunol & Allergy, Lausanne, Switzerland
[6]
South African Med Res Council, HIV Prevent Res Unit, Durban, South Africa
[7]
Ctr Infect Dis Res Zambia, Lusaka, Zambia
[8]
Aurum Inst, Tembisa, South Africa
[9]
GSK Vaccines, Cambridge, MA USA
[10]
Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa
[11]
NIAID, Div Aids, NIH, Bethesda, MD USA
[12]
Aurum Inst, Klerksdorp, South Africa
[13]
NIMR Mbeya Med Res Ctr, Mbeya, Tanzania
[14]
发布时间
2021-06-29
换一批
